Supplementary Figure S3 from TLR4 Is a Novel Determinant of the Response to Paclitaxel in Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S3 - PDF file 379K, Generation of MDA-MB-231 (TLR4-) and HCC1806 (TLR4+) stably modified clones
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362526198
